InNexus Biotechnology (InNexus Biotechnology) Other Net Income (Loss) : $-4.15 Mil (TTM As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Other Net Income (Loss)?

InNexus Biotechnology's Other Net Income (Loss) for the three months ended in Mar. 2011 was $-0.57 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2011 was $-4.15 Mil.

InNexus Biotechnology's quarterly Other Net Income (Loss) increased from Sep. 2010 ($-0.94 Mil) to Dec. 2010 ($-0.79 Mil) and increased from Dec. 2010 ($-0.79 Mil) to Mar. 2011 ($-0.57 Mil).

InNexus Biotechnology's annual Other Net Income (Loss) declined from Jun. 2008 ($-5.79 Mil) to Jun. 2009 ($-7.12 Mil) but then increased from Jun. 2009 ($-7.12 Mil) to Jun. 2010 ($-6.45 Mil).

InNexus Biotechnology Other Net Income (Loss) Historical Data

The historical data trend for InNexus Biotechnology's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Other Net Income (Loss) Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Other Net Income (Loss)

Get a 7-Day Free Trial

-2.63

-4.86

-5.79

-7.12

-6.45

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Other Net Income (Loss)	Get a 7-Day Free Trial															-1.59	-1.84	-0.94	-0.79	-0.57

InNexus Biotechnology Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.15 Mil.

InNexus Biotechnology Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines